The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of ephrins and Eph receptors in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Wang, H. U., Chen, Z.-F., & Anderson, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81436-1 · Cited by 1,669
Mechanisms and functions of eph and ephrin signalling
Kullander, K., & Klein, R. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm856 · Cited by 1,156
Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., Pawson, T., Goldfarb, M., & Yancopoulos, G. D. (1994) · Science · doi:10.1126/science.7973638 · Cited by 710
Miao, H., Burnett, E., Kinch, M., Simon, E., & Wang, B. (2000) · Nature Cell Biology · doi:10.1038/35000008 · Cited by 548
A reevaluation of integrins as regulators of angiogenesis
Hynes, R. O. (2002) · Nature Medicine · doi:10.1038/nm0902-918 · Cited by 548
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling
Himanen, J.-P., Chumley, M. J., Lackmann, M., Li, C., Barton, W. A., Jeffrey, P. D., Vearing, C., Geleick, D., Feldheim, D. A., Boyd, A. W., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1237 · Cited by 453
A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene
Hirai, H., Maru, Y., Hagiwara, K., Nishida, J., & Takaku, F. (1987) · Science · doi:10.1126/science.2825356 · Cited by 441
Stein, E., Lane, A. A., Cerretti, D. P., Schoecklmann, H. O., Schroff, A. D., Van Etten, R. L., & Daniel, T. O. (1998) · Genes & Development · doi:10.1101/gad.12.5.667 · Cited by 424
Ephrin-A5 Induces Collapse of Growth Cones by Activating Rho and Rho Kinase
Wahl, S., Barth, H., Ciossek, T., Aktories, K., & Mueller, B. K. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.263 · Cited by 392
Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., & Salgia, R. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00029-6 · Cited by 391
Self-citationActivation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Miao, H., Wei, B.-R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., & Wang, B. (2001) · Nature Cell Biology · doi:10.1038/35074604 · Cited by 358
Ephrin-B2 and EphB1 Mediate Retinal Axon Divergence at the Optic Chiasm
Williams, S. E., Mann, F., Erskine, L., Sakurai, T., Wei, S., Rossi, D. J., Gale, N. W., Holt, C. E., Mason, C. A., & Henkemeyer, M. (2003) · Neuron · doi:10.1016/j.neuron.2003.08.017 · Cited by 354
Rho family proteins and Ras transformation: the RHOad less traveled gets congested
Zohn, I. M., Campbell, S. L., Khosravi-Far, R., Rossman, K. L., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202181 · Cited by 352
Twigg, S. R. F., Kan, R., Babbs, C., Bochukova, E. G., Robertson, S. P., Wall, S. A., Morriss-Kay, G. M., & Wilkie, A. O. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402819101 · Cited by 343
Crystal structure of an Eph receptor–ephrin complex
Himanen, J.-P., Rajashankar, K. R., Lackmann, M., Cowan, C. A., Henkemeyer, M., & Nikolov, D. B. (2001) · Nature · doi:10.1038/414933a · Cited by 339
The ephrins and Eph receptors in angiogenesis
Cheng, N., Brantley, D. M., & Chen, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00031-4 · Cited by 334
Fibronectin and Its Integrin Receptors in Cancer
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60772-1 · Cited by 330
The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals
Cowan, C. A., & Henkemeyer, M. (2001) · Nature · doi:10.1038/35093123 · Cited by 323
Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers
Hafner, C., Schmitz, G., Meyer, S., Bataille, F., Hau, P., Langmann, T., Dietmaier, W., Landthaler, M., & Vogt, T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026849 · Cited by 323
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205679 · Cited by 316
Eph/ephrin signaling in morphogenesis, neural development and plasticity
Klein, R. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.002 · Cited by 314
EphrinB Phosphorylation and Reverse Signaling
Palmer, A., Zimmer, M., Erdmann, K. S., Eulenburg, V., Porthin, A., Heumann, R., Deutsch, U., & Klein, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00488-4 · Cited by 305
Eph receptors and ephrin ligands: embryogenesis to tumorigenesis
Dodelet, V. C., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203856 · Cited by 296
Hess, A. R., Seftor, E. A., Gardner, L. M., Carles‐Kinch, K., Schneider, G. B., Seftor, R. E. B., Kinch, M. S., & Hendrix, M. J. C. (2001) · PubMed · Cited by 272
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., & Kinch, M. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t · Cited by 269
Adams, R. H., Diella, F., Hennig, S., Helmbacher, F., Deutsch, U., & Klein, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00191-x · Cited by 265
Kullander, K., Mather, N. K., Diella, F., Dottori, M., Boyd, A. W., & Klein, R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00181-7 · Cited by 258
Cheng, N., Brantley, D. M., Liu, H., Lin, Q., Enriquez, M., Gale, N., Yancopoulos, G. D., Cerretti, D. P., Daniel, T. O., & Chen, J. (2002) · PubMed · Cited by 255
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
Zantek, N. D., Azimi, M., Fedor‐Chaiken, M., Wang, B., Brackenbury, R. W., & Kinch, M. S. (1999) · PubMed · Cited by 249
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
Kinch, M. S., Moore, M.-B. H., & Harpole, D. H. (2003) · PubMed · Cited by 235
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
Miyazaki, T., Kato, H., Fukuchi, M., Nakajima, M., & Kuwano, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10860 · Cited by 214
An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor
Koolpe, M., Dail, M., & Pasquale, E. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208495200 · Cited by 211
Molecular Cancer BioMed Central Molecular 12002, Cancer
Lynch, C. A., Tycko, B., Bestor, T. H., & Walsh, C. P. (2002) · Molecular Cancer · doi:10.1186/1476-4598-1-2 · Cited by 202
Huynh-Do, U. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2165 · Cited by 199
Axonal Ephrin-As and Odorant Receptors
Cutforth, T., Moring, L., Mendelsohn, M., Nemes, A., Shah, N. M., Kim, M. M., Frisén, J., & Axel, R. (2003) · Cell · doi:10.1016/s0092-8674(03)00568-3 · Cited by 196
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Carles‐Kinch, K., Kilpatrick, K. E., Stewart, J. C., & Kinch, M. S. (2002) · PubMed · Cited by 195
Eph receptor–ephrin bidirectional signals that target Ras and Rho proteins
Noren, N. K., & Pasquale, E. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.10.006 · Cited by 194
An Eph receptor regulates integrin activity through R-Ras
Zou, J. X., Wang, B., Kalo, M. S., Zisch, A. H., Pasquale, E. B., & Ruoslahti, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13813 · Cited by 192
EphrinA1-induced cytoskeletal re-organization requires FAK and p130cas
Carter, N., Nakamoto, T., Hirai, H., & Hunter, T. (2002) · Nature Cell Biology · doi:10.1038/ncb823 · Cited by 186
Steinle, J. J., Meininger, C. J., Forough, R., Wu, G., Wu, M. H., & Granger, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207221200 · Cited by 181
Fox, B. P., & Kandpal, R. P. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.102 · Cited by 175
Füller, T., Korff, T., Kilian, A., Dandekar, G., & Augustin, H. G. (2003) · Journal of Cell Science · doi:10.1242/jcs.00426 · Cited by 172
Lawrenson, I. D., Wimmer-Kleikamp, S. H., Lock, P., Schoenwaelder, S. M., Down, M., Boyd, A. W., Alewood, P. F., & Lackmann, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.1059 · Cited by 169
Himanen, J.-P., & Nikolov, D. B. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00096-1 · Cited by 169
Eph–ephrin promiscuity is now crystal clear
Pasquale, E. B. (2004) · Nature Neuroscience · doi:10.1038/nn0504-417 · Cited by 166
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
Dohn, M. R., Jiang, J., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204816 · Cited by 161
Zhang, J., Cerretti, D. P., Yu, T., Flanagan, J. G., & Zhou, R. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07182.1996 · Cited by 155
Motility and invasion are differentially modulated by Rho family GTPases
Banyard, J., Anand‐Apte, B., Symons, M. H., & Zetter, B. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203338 · Cited by 148
Up-regulation of ephrin-a1 during melanoma progression
Easty, D. J., Hill, S. P., Hsu, M., Fallowfield, M. E., Flørenes, V. A., Herlyn, M., & Bennett, D. C. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o · Cited by 135
Expression of Eph receptors and ephrins is differentially regulated by E-cadherin
Oršulić, S., & Kemler, R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1793 · Cited by 119
Phosphoinositide 3-kinase and the regulation of cell growth
Carpenter, C. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00018-2 · Cited by 118
High-Level Expression of EphA2 Receptor Tyrosine Kinase in Prostatic Intraepithelial Neoplasia
Zeng, G., Hu, Z., Kinch, M. S., Pan, C.-X., Flockhart, D. A., Kao, C. H., Gardner, T. A., Zhang, S., Li, L., Baldridge, L. A., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63584-5 · Cited by 114
Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor
Yu, H.-H., Zisch, A. H., Dodelet, V. C., & Pasquale, E. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204524 · Cited by 112
Easty, D. J., Guthrie, B. A., Maung, K., et al. (1995) · PubMed · Cited by 108
Ephrin-A5 Exerts Positive or Inhibitory Effects on Distinct Subsets of EphA4-Positive Motor Neurons
Eberhart, J. K., Barr, J., O’Connell, S., Flagg, A. E., Swartz, M. E., Cramer, K. S., Tosney, K. W., Pasquale, E. B., & Krull, C. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4719-03.2004 · Cited by 106
Jones, T. L., Chong, L. D., Kim, J., Xu, R., Kung, H., & Daar, I. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.576 · Cited by 89
Dottori, M., Down, M., Hüttmann, A., Fitzpatrick, D. R., & Boyd, A. (1999) · Blood · doi:10.1182/blood.v94.7.2477.419k13_2477_2486 · Cited by 85
Identification of the Jak/Stat Proteins as Novel Downstream Targets of EphA4 Signaling in Muscle
Lai, K., Chen, Y., Po, H. M., Lok, K.-C., Gong, K., & Ip, N. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313356200 · Cited by 84
Ephrin-A1 Induces c-Cbl Phosphorylation and EphA Receptor Down-Regulation in T Cells
Sharfe, N., Freywald, A., Toro-Montoya, A. I., & Roifman, C. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6024 · Cited by 72
EphB1-mediated Cell Migration Requires the Phosphorylation of Paxillin at Tyr-31/Tyr-118
Vindis, C., Teli, T., Cerretti, D. P., Turner, C. E., & Huynh‐Do, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401295200 · Cited by 68
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.
Alves, P. M. S., Faure, O., Graff‐Dubois, S., Gross, D., Cornet, S., Chouaı̈b, S., Miconnet, I., Lemonnier, F. A., & Kosmatopoulos, K. (2003) · PubMed · Cited by 55
Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
Pisick, E. P., Jagadeesh, S., & Salgia, R. (2004) · The Scientific World JOURNAL · doi:10.1100/tsw.2004.117 · Cited by 46
Self-citation
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Tauro, B. J., Greening, D. W., Mathias, R. A., Ji, H., Mathivanan, S., Scott, A. M., & Simpson, R. J. (2012) · Methods · doi:10.1016/j.ymeth.2012.01.002 · Cited by 1,176
MOLECULAR GRADIENTS AND DEVELOPMENT OF RETINOTOPIC MAPS
McLaughlin, T., & O'Leary, D. D. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135714 · Cited by 411
Metadata
- Authors
- Surawska, H., Ma, P. C., & Salgia, R.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 15
- Issue
- 6
- Pages
- 419-433
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2033124377
- Cited by
- 341
- References
- 66
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.